MedicinePOM

Secukinumab

A biologic injection (IL-17A blocker) for psoriasis and related inflammatory conditions.

Clinical information

Common uses

moderate to severe plaque psoriasis
psoriatic arthritis
ankylosing spondylitis and related spine arthritis
hidradenitis suppurativa

Common side effects

cold-like symptoms (nasopharyngitis)
diarrhoea
upper respiratory tract infection

Cautions

can raise the risk of serious infections
TB check needed before starting
may worsen inflammatory bowel disease
severe allergic reactions can occur

Interactions

live vaccines — avoid
certain CYP450-metabolised drugs — monitoring or dose changes may be needed

Pregnancy: limited human data — talk to your doctor

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, secukinumab (Cosentyx) label, setid 77c4b13e-7df3-42d4-81db-3d0cddb7f67a (accessed 2026-08-16)

Approved brands & formulations2

Brand name	Dosage form	Strength	Importer	Category
Cosentyx	Parenteral ( Injection- Solution )	150 mg/mL	ADK Pharmaceutical Company Pvt. Ltd	POM
Secukinumab	Parenteral ( Injection- prefilled )	300mg	—	POM